Global Postoperative Nausea and Vomiting (PONV) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application

The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.

Market Analysis and Insights: Global Postoperative Nausea and Vomiting (PONV) Market
The research report studies the Postoperative Nausea and Vomiting (PONV) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Postoperative Nausea and Vomiting (PONV) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

Global Postoperative Nausea and Vomiting (PONV) Scope and Segment
The global Postoperative Nausea and Vomiting (PONV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline